Medexus Pharma: Bottom 25 Performing Stocks Year-to-Date on TSX (MDP)
Medexus Pharmaceuticals Inc is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.
This report is generated monthly. It highlights the 25 companies with the greatest percentage decrease in share price year-to-date. Stocks in this category are generally sold to preserve capital or held for speculation.
Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bearish changes in sector outlook, or the company is experiencing financial difficulties generally due to an inability to service its debt.
| Symbol | Name | Total Return | Period |
|---|---|---|---|
| GMTN | Gold Mountain Mining Corp | -72.727273 | YTD |
| HZM | Horizonte Minerals PLC | -63.157895 | YTD |
| SSRM | SSR Mining Inc | -61.954993 | YTD |
| ATE | Antibe Therapeutics Inc | -53.763441 | YTD |
| BCT | BriaCell Therapeutics Corp | -50.128205 | YTD |
| ELR | Eastern Platinum Ltd | -45.945946 | YTD |
| ELO | Eloro Resources Ltd | -41.935484 | YTD |
| EXRO | Exro Technologies Inc | -41.40625 | YTD |
| ECN | ECN Capital Corp | -40 | YTD |
| AUMN | Golden Minerals Co | -39.705882 | YTD |
| APS | Aptose Biosciences Inc | -38.80597 | YTD |
| EGLX | Enthusiast Gaming Holdings Inc | -38.596491 | YTD |
| MDP | Medexus Pharmaceuticals Inc | -38.461538 | YTD |
| CNE | Canacol Energy Ltd | -38.362069 | YTD |
| NEXT | NextSource Materials Inc | -37.5 | YTD |
| AR | Argonaut Gold Inc | -36.170213 | YTD |
| NUAG | New Pacific Metals Corp | -35.059761 | YTD |
| WM | Wallbridge Mining Co Ltd | -35 | YTD |
| SGNL | Signal Gold Inc | -33.333333 | YTD |
| VRTS | Vertiqal Studios | -33.333333 | YTD |
| TC | Tucows Inc | -33.100754 | YTD |
| LSPD | Lightspeed Commerce Inc | -32.674335 | YTD |
| AVNT | Avant Brands Inc | -32.142857 | YTD |
| LGO | Largo Inc | -32.131148 | YTD |
| MPCT-UN | Dream Impact Trust | -31.653171 | YTD |
All data provided as of March 25, 2024.
More about Medexus Pharmaceuticals Inc
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.
Medexus Pharmaceuticals Inc is listed under MDP on the Toronto Stock Exchange.
Artificial intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
